Physician profile
Paul B Jacob
NPI 1548433345
$821,990.68
in general payments reported to CMS, 2019-2025
26 companies · $207K in 2025
The $207K reported for 2025 was more than what 95% of Adult Reconstructive Orthopaedic Surgery providers received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $79K · 2020: $96K · 2021: $93K · 2022: $71K · 2023: $118K · 2024: $160K · 2025: $207K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $420K · Travel and Lodging: $53K · Food and Beverage: $11K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $420,402.50 |
| Travel and Lodging | $52,758.56 |
| Food and Beverage | $10,786.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $797,644.77 | 2019-2025 | Mako, Accolade, Triathlon |
| B. Braun Medical INC. | $10,000.00 | 2021 | |
| Pacira Therapeutics, INC. | $5,082.73 | 2020-2021 | |
| Orthosensor INC. | $4,409.72 | 2019-2020 | |
| Kci USA, INC. | $1,616.72 | 2019-2022 | |
| Medtronic Vascular, INC. | $1,384.23 | 2019 | |
| Think Surgical, INC. | $310.41 | 2023-2025 | |
| Zimmer Biomet Holdings, INC. | $265.15 | 2023-2025 | Rosa, Persona, Mymobility Platform |
| Conmed Corporation | $236.45 | 2022-2023 | Airseal, System 2450 |
| Arthrex, INC. | $206.33 | 2021-2023 | |
| Bone Support INC. | $133.96 | 2019 | |
| Ethicon US, LLC | $106.03 | 2020-2025 | Stratafix, Ethicon |
| Pylant Medical | $89.64 | 2022-2023 | |
| Heron Therapeutics, INC. | $79.94 | 2024-2025 | Zynrelef, Aponvie |
| Smith+Nephew, INC. | $71.15 | 2019-2023 | Journey II, Or3o Dual Mobility |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $67.95 | 2021 | |
| Biotissue Holdings INC. | $65.26 | 2024 | |
| Avanos Medical | $49.82 | 2025 | Pnb and Accessories |
| Pacira Pharmaceuticals Incorporated | $44.92 | 2025 | Zilretta, Iovera, Exparel |
| Molnlycke Health Care US, LLC | $26.20 | 2023-2025 | Avance, Mepilex Border Post-Op Ag, Mepilex Border Post-Op |
| Heraeus Medical, LLC. | $25.59 | 2019 | |
| Horizon Therapeutics Plc | $19.44 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $18.87 | 2025 | |
| Deroyal Industries, INC. | $15.46 | 2025 | Prospera Flex Negative Pressure Wound Therapy System |
| Aesculap Implant Systems, LLC | $13.98 | 2020 | |
| Omnilife Science, INC | $5.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Jacob listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.